Quality of life predicts cancer survival, U-M study findsMay 30, 2008Assessment could help identify more aggressive head and neck tumors ANN ARBOR, Mich. - Head and neck cancer patients who reported lower physical quality of life were more likely to die from their disease, according to a new study from the University of Michigan Comprehensive Cancer Center. The findings could mean that identifying patients with poor quality of life could also identify patients with particularly aggressive tumors. "Low quality of life may have value in screening patients for recurrence. By identifying patients with poor quality of life, we may also be able to identify early on those who have particularly aggressive tumors," says lead study author Carrie A. Karvonen-Gutierrez, M.P.H., research associate at the U-M School of Public Health and the VA Ann Arbor Healthcare System.
Results of the study appear in the June 1 issue of the Journal of Clinical Oncology. The researchers surveyed 495 people at four hospitals who had been diagnosed with head and neck cancer within the previous two years. Participants responded to questions about physical and emotional quality of life, including pain, eating and swallowing, speech and emotional well-being. The researchers found that general physical health and quality of life issues were highly associated with survival. And in particular, patients who reported difficulty with pain, eating and speech were significantly less likely to survive. The researchers suggest that pain and declines in other physical quality of life measures could be a marker for cancer recurrence. "Our findings validate the concept that doctors have long recognized: that persistent or increasing pain is a worrisome clinical finding. Perhaps in the future, quality of life data will be routinely collected in a standardized way, and trends in pain scores will trigger more aggressive examinations for cancer recurrence," says study author Sonia A. Duffy, Ph.D., R.N., a research scientist at the VA Ann Arbor Healthcare System, associate professor of nursing at the U-M School of Nursing and research assistant professor of otolaryngology at the U-M Medical School. "While patients are monitored and screened after cancer treatment, small recurrences of cancer may be difficult to detect, even with standard imaging techniques. But, for example, small islands of cancer near a nerve can cause substantial pain before the cancer is detected on routine examination or imaging scans," says study author Jeffrey Terrell, M.D., associate professor of otolaryngology at the U-M Medical School. The next question for the researchers is to understand whether treatments that improve quality of life can improve survival. "Although it is not yet clear how the association works between survival and quality of life related to head and neck pain, it is clearly advantageous to minimize pain for patients. And, if in doing that, the chance of cancer recurrence or patient survival is improved, the effort is worthwhile, regardless of why these factors are related. Patients want improved quality of life after cancer treatment-whether it be to improve survival or simply to improve everyday living and feel better," Duffy says. Based on their findings, the study authors recommend routine quality of life assessments of patients with head and neck cancer, before treatment and again after six months, one year and two years. University of Michigan Health System | |||||||||||||||||||||
|
Related Cancer Survival News Articles Low vitamin D levels associated with increased risk of death Individuals with low levels of vitamin D appear to have a higher risk of death from all causes, according to a report in the August 11/25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. First worldwide analysis of cancer survival finds wide variation between countries Cancer survival varies widely between countries according to a worldwide study published online today in Lancet Oncology.* More than 100 investigators contributed to the study. Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis Cancer patients with low socioeconomic status (SES) have more advanced cancers at diagnosis, receive less aggressive treatment, and have a higher risk of dying in the five years following cancer diagnosis, according to a new study. Breast cancers behave differently before and after the age of 70 Researchers in Belgium have discovered that increasing age affects the way breast cancer behaves. As women approach the age of 70, they become less likely to be diagnosed with aggressive tumours that have spread to the lymph nodes. But after 70, the cancer is increasingly likely to spread, particularly if the tumours are small. Health Insurance Co-Payments Deter Mammography Use When faced with even a modest health insurance co-payment for a mammogram, significantly fewer women receive these potentially life-saving breast cancer screenings, according to a new study by Brown University and Harvard Medical School researchers. Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene Israeli investigators have found that Ashkenazi Jewish women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes lived significantly longer than Ashkenazi Jewish ovarian cancer patients without these mutations. Treating oft ignored non-cancer health issues after cancer diagnosis prolongs survival Receiving treatment for non-cancer health issues while being treated by specialists for cancer improves cancer survival rates according to a study published in the December 20 issue of the Journal of Clinical Oncology. Ireland Cancer Center researcher finds standard treatment for breast cancer not followed Research out of the Ireland Cancer Center of University Hospitals Case Medical Center, in collaboration with six integrated health plans that are part of the Cancer Research Network, found that the majority of older women with early stage breast cancer fail to adhere to the standard of treatment - five years of daily oral use of the chemo-prevention drug Tamoxifen. New report estimates 12 million cancer cases worldwide A new American Cancer Society report estimates that there will be over 12 million new cancer cases and 7.6 million cancer deaths (about 20,000 cancer deaths a day) worldwide in 2007. PSA velocity's clinical usefulness remains unclear Some studies have suggested that the rate of change of prostate-specific antigen (PSA) levels may correspond with prostate cancer survival. But this does not necessarily mean that PSA velocity will be valuable as a prostate cancer screening tool. More Cancer Survival News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||